Form 4: ANI Pharmaceuticals Executive Meredith Cook Sells 250 Shares
SEC Form 4
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 250 shares of common stock on June 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On June 13, 2024, Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 250 shares of common stock at a price of $63.8 per share.
- The transaction was executed under a Rule 10b5-1 trading plan adopted on August 11, 2023.
- Following the transaction, Meredith Cook directly owns 59,231 shares of ANI Pharmaceuticals.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of an insider transaction. It's common for executives to use Rule 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 08/11/2023 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| 06/13/2024 | Date of the transaction (stock sale) |
| 06/14/2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.